Paclitaxel and Cisplatin for Thymic Neoplasm

NCT00818090 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

39

Enrollment

OTHER

Sponsor class

Stopped marginal statistical significance

Conditions

Thymoma
Thymic Carcinoma

Interventions

DRUG: paclitaxel and cisplatin

Sponsor

Korean Cancer Study Group